GPT and metabolic dysfunction-associated steatotic liver disease: In terms of hepatoprotective effects of CSO, Musazadeh et al. in a clinical trial study on NAFLD patients showed that CSO supplementation led to a significant decrease in alanine aminotransferase, an enzyme indicating a poor liver function in high levels.